Literature DB >> 33516407

Atrial Fibrillation and Heart Failure: Epidemiology, Pathophysiology, Prognosis, and Management.

Jonathan P Ariyaratnam1, Dennis H Lau1, Prashanthan Sanders1, Jonathan M Kalman2.   

Abstract

Atrial fibrillation (AF) and heart failure (HF) have similar risk factors, frequently coexist, and potentiate each other in a vicious cycle. Evidence suggests the presence of AF in both HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF) increases the risk of all-cause mortality and stroke, particularly when AF is incident. Catheter ablation may be an effective strategy in controlling symptoms and improving quality of life in AF-HFrEF. Strong data guiding management of AF-HFpEF are lacking largely due to its challenging diagnosis. Improving outcomes associated with these coexistent conditions requires further careful investigation.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Heart failure (HF); Heart failure with preserved ejection fraction (HFpEF); Heart failure with reduced ejection fraction (HFrEF)

Year:  2021        PMID: 33516407     DOI: 10.1016/j.ccep.2020.11.004

Source DB:  PubMed          Journal:  Card Electrophysiol Clin        ISSN: 1877-9182


  5 in total

Review 1.  Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis.

Authors:  Joanna M Bilak; Uazman Alam; Christopher A Miller; Gerry P McCann; Jayanth R Arnold; Prathap Kanagala
Journal:  Card Fail Rev       Date:  2022-07-01

2.  Plasma acylcarnitines and risk of incident heart failure and atrial fibrillation: the Prevención con dieta mediterránea study.

Authors:  Miguel Ruiz-Canela; Marta Guasch-Ferré; Cristina Razquin; Estefanía Toledo; Pablo Hernández-Alonso; Clary B Clish; Jun Li; Clemens Wittenbecher; Courtney Dennis; Ángel Alonso-Gómez; Enrique Almanza-Aguilera; Liming Liang; Dolores Corella; Enrique Gómez-Gracia; Ramón Estruch; Miguel Fiol; José Lapetra; Lluis Serra-Majem; Emilio Ros; Fernando Arós; Jordi Salas-Salvadó; Frank B Hu; Miguel Ángel Martínez-González
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2021-12-02

3.  Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation.

Authors:  Jonathan P Ariyaratnam; Adrian D Elliott; Ricardo S Mishima; Celine Gallagher; Dennis H Lau; Prashanthan Sanders
Journal:  Heart Rhythm O2       Date:  2021-12-17

4.  Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation.

Authors:  Jose Miguel Calderon; Fernando Martinez; Javier Diaz; Antonio Fernandez; Inmaculada Sauri; Ruth Uso; Jose Luis Trillo; Sara Vela; Carlos Bea; Josep Redon; Maria Jose Forner
Journal:  Front Cardiovasc Med       Date:  2022-01-21

5.  Impact of preexisting diabetes mellitus on cardiovascular and all-cause mortality in patients with atrial fibrillation: A meta-analysis.

Authors:  Juan Xu; Yimeng Sun; Dandan Gong; Yu Fan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-01       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.